Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Mol Sci ; 21(15)2020 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-32727075

RESUMEN

Brain and other nervous system cancers are the 10th leading cause of death worldwide. Genome instability, cell cycle deregulation, epigenetic mechanisms, cytoarchitecture disassembly, redox homeostasis as well as apoptosis are involved in carcinogenesis. A diet rich in fruits and vegetables is inversely related with the risk of developing cancer. Several studies report that cruciferous vegetables exhibited antiproliferative effects due to the multi-pharmacological functions of their secondary metabolites such as isothiocyanate sulforaphane deriving from the enzymatic hydrolysis of glucosinolates. We treated human astrocytoma 1321N1 cells for 24 h with different concentrations (0.5, 1.25 and 2.5% v/v) of sulforaphane plus active myrosinase (Rapha Myr®) aqueous extract (10 mg/mL). Cell viability, DNA fragmentation, PARP-1 and γH2AX expression were examined to evaluate genotoxic effects of the treatment. Cell cycle progression, p53 and p21 expression, apoptosis, cytoskeleton morphology and cell migration were also investigated. In addition, global DNA methylation, DNMT1 mRNA levels and nuclear/mitochondrial sirtuins were studied as epigenetic biomarkers. Rapha Myr® exhibited low antioxidant capability and exerted antiproliferative and genotoxic effects on 1321N1 cells by blocking the cell cycle, disarranging cytoskeleton structure and focal adhesions, decreasing the integrin α5 expression, renewing anoikis and modulating some important epigenetic pathways independently of the cellular p53 status. In addition, Rapha Myr® suppresses the expression of the oncogenic p53 mutant protein. These findings promote Rapha Myr® as a promising chemotherapeutic agent for integrated cancer therapy of human astrocytoma.


Asunto(s)
Anoicis/efectos de los fármacos , Protocolos de Quimioterapia Combinada Antineoplásica/farmacología , Astrocitoma/metabolismo , Metilación de ADN/efectos de los fármacos , ADN de Neoplasias/metabolismo , Proteínas de Neoplasias/metabolismo , Sirtuinas/metabolismo , Astrocitoma/tratamiento farmacológico , Astrocitoma/patología , Línea Celular Tumoral , Glicósido Hidrolasas/farmacología , Humanos , Isotiocianatos/farmacología , Sulfóxidos
2.
Mech Ageing Dev ; 190: 111295, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32592713

RESUMEN

Cell senescence - an irreversible proliferation arrest - is one of the possible cellular responses to stress. There is a vast variety of stimuli, extrinsic and intrinsic, known to induce senescence, and several molecular pathways involved in the process; yet much still remains to be explained. Senescent cells can communicate with neighboring cells through secreted factors such as cytokines and chemokines. Several years ago it was shown that cells can also communicate in a more direct manner by an exchange of proteins via cellular bridges (CBs). Recent studies show that in senescent cells the intensity of such transfer increases. The research also revealed that Cdc42 and actin polymerization are indispensable for this process to occur. Here, we evaluate the hypothesis that, apart from actin and Cdc42, also IQGAP1 could be involved in direct intercellular communication. Our results showed that direct transfer occurred preferentially between senescent cells and that IQGAP1 was not essential for this process. Interestingly, cells harboring mutated IQGAP1 had altered morphology and were characterized by decreased proliferation, increased time of division and appearance of some senescence markers (increased activity of senescence-associated ß-galactosidase and induction of senescence-associated secretory phenotype). Our findings suggest that IQGAP1 dysfunction can induce senescence.


Asunto(s)
Actinas/metabolismo , Comunicación Celular/fisiología , Senescencia Celular/fisiología , Músculo Liso Vascular/metabolismo , Proteína de Unión al GTP cdc42/metabolismo , Proteínas Activadoras de ras GTPasa/metabolismo , Proliferación Celular , Células Cultivadas , Humanos , Miocitos del Músculo Liso/metabolismo , beta-Galactosidasa/metabolismo
3.
Biogerontology ; 20(6): 783-798, 2019 12.
Artículo en Inglés | MEDLINE | ID: mdl-31372798

RESUMEN

Curcumin, a phytochemical present in the spice named turmeric, and one of the promising anti-aging factors, is itself able to induce cellular senescence. We have recently shown that cells building the vasculature senesced as a result of curcumin treatment. Curcumin-induced senescence was DNA damage-independent; however, activation of ATM was observed. Moreover, neither increased ROS production, nor even ATM were indispensable for senescence progression. In this paper we tried to elucidate the mechanism of curcumin-induced senescence. We analyzed the time-dependence of the level and activity of numerous proteins involved in senescence progression in vascular smooth muscle cells and how inhibition p38 or p38 together with ATM, two proteins involved in canonical signaling pathways, influenced cell senescence. We showed that curcumin was able to influence many signaling pathways of which probably none was dominant and sufficient to induce senescence by itself. However, we cannot exclude that the switch between initiation and progression of senescence is the result of the impact of curcumin on signaling pathways engaging AMPK, ATM, sirtuin 1 and p300 and on their reciprocal interplay. Cytostatic concentration of curcumin induced cellular stress, which exceeded the adaptive response and, in consequence, led to cellular senescence, which is triggered by time dependent activation of several signaling pathways playing diverse roles in different phases of senescence progression. We also showed that activity of ß-glucuronidase, the enzyme involved in deconjugation of the main metabolites of curcumin, glucuronides, increased in senescent cells. It suggests a possible local elevation of curcumin concentration in the organism.


Asunto(s)
Senescencia Celular/efectos de los fármacos , Curcumina/farmacología , Músculo Liso Vascular/efectos de los fármacos , Transducción de Señal/efectos de los fármacos , Proteínas de la Ataxia Telangiectasia Mutada/genética , Regulación hacia Abajo , Silenciador del Gen , Glucuronidasa/metabolismo , Humanos , Músculo Liso Vascular/enzimología , Músculo Liso Vascular/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/antagonistas & inhibidores
4.
Int J Mol Sci ; 20(5)2019 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-30871021

RESUMEN

It is believed that postponing ageing is more effective and less expensive than the treatment of particular age-related diseases. Compounds which could delay symptoms of ageing, especially natural products present in a daily diet, are intensively studied. One of them is curcumin. It causes the elongation of the lifespan of model organisms, alleviates ageing symptoms and postpones the progression of age-related diseases in which cellular senescence is directly involved. It has been demonstrated that the elimination of senescent cells significantly improves the quality of life of mice. There is a continuous search for compounds, named senolytic drugs, that selectively eliminate senescent cells from organisms. In this paper, we endeavor to review the current knowledge about the anti-ageing role of curcumin and discuss its senolytic potential.


Asunto(s)
Envejecimiento/efectos de los fármacos , Curcumina/farmacología , Curcumina/uso terapéutico , Animales , Senescencia Celular/efectos de los fármacos , Humanos , Longevidad/efectos de los fármacos , Calidad de Vida
5.
Biogerontology ; 18(4): 447-476, 2017 08.
Artículo en Inglés | MEDLINE | ID: mdl-28258519

RESUMEN

Ageing is a plastic process and can be successfully modulated by some biomedical approaches or pharmaceutics. In this manner it is possible to delay or even prevent some age-related pathologies. There are some defined interventions, which give promising results in animal models or even in human studies, resulting in lifespan elongation or healthspan improvement. One of the most promising targets for anti-ageing approaches are proteins belonging to the sirtuin family. Sirtuins were originally discovered as transcription repressors in yeast, however, nowadays they are known to occur in bacteria and eukaryotes (including mammals). In humans the family consists of seven members (SIRT1-7) that possess either mono-ADP ribosyltransferase or deacetylase activity. It is believed that sirtuins play key role during cell response to a variety of stresses, such as oxidative or genotoxic stress and are crucial for cell metabolism. Although some data put in question direct involvement of sirtuins in extending human lifespan, it was documented that proper lifestyle including physical activity and diet can influence healthspan via increasing the level of sirtuins. The search for an activator of sirtuins is one of the most extensive and robust topic of research. Some hopes are put on natural compounds, including curcumin. In this review we summarize the involvement and usefulness of sirtuins in anti-ageing interventions and discuss the potential role of curcumin in sirtuins regulation.


Asunto(s)
Envejecimiento/metabolismo , Senescencia Celular , Transducción de Señal , Sirtuinas/metabolismo , Factores de Edad , Envejecimiento/efectos de los fármacos , Animales , Senescencia Celular/efectos de los fármacos , Curcumina/farmacología , Activación Enzimática , Activadores de Enzimas/farmacología , Regulación de la Expresión Génica , Humanos , Conformación Proteica , Transducción de Señal/efectos de los fármacos , Sirtuinas/química , Relación Estructura-Actividad
6.
Oncotarget ; 7(15): 19201-13, 2016 Apr 12.
Artículo en Inglés | MEDLINE | ID: mdl-27034011

RESUMEN

It is believed that curcumin, a component of the turmeric that belongs to hormetins, possesses anti-aging propensity. This property of curcumin can be partially explained by its influence on the level of sirtuins. Previously, we have shown that relatively high (2.5-10 µM) doses of curcumin induce senescence of cancer cells and cells building the vasculature. In the present study we examined whether curcumin at low doses (0.1 and 1 µM) is able to delay cell senescence and upregulate the level of sirtuins in human cells building the vasculature, namely vascular smooth muscle (VSMC) and endothelial (EC) cells. To this end we used cells senescing in a replicative and premature manner. We showed that low doses of curcumin in case of VSMC neither postponed the replicative senescence nor protected from premature senescence induced by doxorubicin. Moreover, curcumin slightly accelerated replicative senescence of EC. Despite some fluctuations, a clear increasing tendency in the level of sirtuins was observed in curcumin-treated young, senescing or already senescent cells. Sirtuin activation could be caused by the activation of AMPK resulting from superoxide elevation and ATP reduction. Our results show that curcumin at low doses can increase the level of sirtuins without delaying senescence of VSMC.


Asunto(s)
Senescencia Celular/efectos de los fármacos , Curcumina/farmacología , Células Endoteliales/efectos de los fármacos , Miocitos del Músculo Liso/efectos de los fármacos , Sirtuinas/metabolismo , Proteínas Quinasas Activadas por AMP/metabolismo , Adenosina Trifosfato/metabolismo , Antineoplásicos/farmacología , Western Blotting , Proliferación Celular/efectos de los fármacos , Células Cultivadas , Relación Dosis-Respuesta a Droga , Doxorrubicina/farmacología , Células Endoteliales/metabolismo , Humanos , Músculo Liso Vascular/citología , Miocitos del Músculo Liso/metabolismo , Sirtuina 1/metabolismo , Sirtuina 3/metabolismo , Superóxidos/metabolismo
7.
Int J Biochem Cell Biol ; 74: 33-43, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26916504

RESUMEN

Cellular senescence is recognized as a potent anticancer mechanism that inhibits carcinogenesis. Cancer cells can also undergo senescence upon chemo- or radiotherapy. Curcumin, a natural polyphenol derived from the rhizome of Curcuma longa, shows anticancer properties both in vitro and in vivo. Previously, we have shown that treatment with curcumin leads to senescence of human cancer cells. Now we identified the molecular mechanism underlying this phenomenon. We observed a time-dependent accumulation of mitotic cells upon curcumin treatment. The time-lapse analysis proved that those cells progressed through mitosis for a significantly longer period of time. A fraction of cells managed to divide or undergo mitotic slippage and then enter the next phase of the cell cycle. Cells arrested in mitosis had an improperly formed mitotic spindle and were positive for γH2AX, which shows that they acquired DNA damage during prolonged mitosis. Moreover, the DNA damage response pathway was activated upon curcumin treatment and the components of this pathway remained upregulated while cells were undergoing senescence. Inhibition of the DNA damage response decreased the number of senescent cells. Thus, our studies revealed that the induction of cell senescence upon curcumin treatment resulted from aberrant progression through the cell cycle. Moreover, the DNA damage acquired by cancer cells, due to mitotic disturbances, activates an important molecular mechanism that determines the potential anticancer activity of curcumin.


Asunto(s)
Senescencia Celular/efectos de los fármacos , Curcumina/farmacología , Mitosis/efectos de los fármacos , Antineoplásicos/farmacología , Western Blotting , Línea Celular Tumoral , Humanos , Inmunohistoquímica
8.
Artículo en Inglés | MEDLINE | ID: mdl-25813723

RESUMEN

Capsaicin is the major pungent component of the hot chili peppers of the genus Capsicum, which are consumed worldwide as a food additive. More recently, the selective action of capsaicin against cancer cells has been reported. Capsaicin was found to induce apoptosis and inhibit proliferation of a wide range of cancer cells in vitro, whereas being inactive against normal cells. As data on capsaicin-induced genotoxicity are limited and the effects of capsaicin against human lung A549 and DU145 prostate cancer cells were not explored in detail, we were interested in determining whether capsaicin-associated genotoxicity may also provoke A549 and DU145 cell death. Capsaicin-induced decrease in metabolic activity and cell proliferation, and changes in the cell cycle were limited to high concentrations used (≥ 100 µM), whereas, at lower concentrations, capsaicin stimulated both DNA double strand breaks and micronuclei production. Capsaicin was unable to provoke apoptotic cell death when used up to 250 µM concentrations. Capsaicin induced oxidative stress, but was ineffective in provoking the dissipation of the mitochondrial inner transmembrane potential. A different magnitude of p53 binding protein 1 (53BP1) recruitment contributed to diverse capsaicin-induced genotoxic effects in DU145 and A549 cells. Capsaicin was also found to be a DNA hypermethylating agent in A549 cells. In summary, we have shown that genotoxic effects of capsaicin may contribute to limited susceptibility of DU145 and A549 cancer cells to apoptosis in vitro, which may question the usefulness of capsaicin-based anticancer therapy, at least in a case of lung and prostate cancer.


Asunto(s)
Apoptosis/efectos de los fármacos , Capsaicina/farmacología , Daño del ADN/efectos de los fármacos , Capsicum/química , Ciclo Celular/efectos de los fármacos , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Aberraciones Cromosómicas/efectos de los fármacos , Ensayo Cometa , Epigénesis Genética/efectos de los fármacos , Humanos , Concentración 50 Inhibidora , Neoplasias Pulmonares/metabolismo , Masculino , Potencial de la Membrana Mitocondrial/genética , Estrés Oxidativo/efectos de los fármacos , Neoplasias de la Próstata/metabolismo , Especies Reactivas de Oxígeno/metabolismo
9.
Age (Dordr) ; 37(1): 9744, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25649709

RESUMEN

Curcumin is considered not only as a supplement of the diet but also as a drug in many types of diseases and even as a potential anti-aging compound. It can reduce inflammation that increases with age and accompanies almost all age-related diseases. It has been suggested that curcumin can play a beneficial role in the cardiovascular system. However, there are also data showing that curcumin can induce senescence in cancer cells, which is a beneficial effect in cancer therapy but an undesirable one in the case of normal cells. It is believed that cellular senescence accompanies age-related changes in the cardiovascular system. The aim of this study was to check if curcumin, in a certain range of concentrations, can induce senescence in cells building the vasculature. We have found that human vascular smooth muscle and endothelial cells derived from aorta are very sensitive to curcumin treatment and can senesce upon treatment with cytostatic doses. We observed characteristic senescence markers but the number of DNA damage foci decreased. Surprisingly, in vascular smooth muscle cell (VSMC) activation of DNA damage response pathway downstream of ataxia-telangiectasia mutated (ATM) was observed. ATM silencing and the supplementation of antioxidants, N-acetyl-L-cysteine (NAC) or trolox, did not reduce the number of senescent cells. Thus, we have shown that curcumin can induce senescence of cells building the vasculature, which is DNA damage and ATM independent and is not induced by increased reactive oxygen species (ROS) level. We postulate that an increase in the bioavailability of curcumin should be introduced very carefully considering senescence induction as a side effect.


Asunto(s)
Antiinflamatorios no Esteroideos/farmacología , Senescencia Celular/efectos de los fármacos , Curcumina/farmacología , Células Endoteliales/efectos de los fármacos , Músculo Liso Vascular/efectos de los fármacos , Miocitos del Músculo Liso/efectos de los fármacos , Aorta/efectos de los fármacos , Aorta/patología , Proteínas de la Ataxia Telangiectasia Mutada , Técnicas de Cultivo de Célula , Proliferación Celular/efectos de los fármacos , Daño del ADN , Humanos , Músculo Liso Vascular/patología
10.
Toxicol Lett ; 233(3): 227-38, 2015 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-25644192

RESUMEN

It is widely accepted that abnormal accumulation of vascular smooth muscle cells (VSMCs) may promote atherosclerosis and post-angioplasty restenosis. The use of some plant polyphenols with potent antiproliferative activities may be considered as a therapeutic intervention to diminish/prevent the development of cardiovascular pathologies. In the present study, VSMC response to curcumin treatment was evaluated. 5 µM curcumin elicited a cytostatic effect, which was accompanied by protein carbonylation, oxidative DNA damage and changes in the nucleolar activity (the size and number of nucleoli, nucleolar protein levels and their localization). The levels of p53 and p21 were elevated. However, this was independent of DNA DSBs. Curcumin caused inhibition of rDNA transcription, which could be due to SIRT7 downregulation, site-specific methylation of RNA18S5 gene promoter or both. Curcumin-induced DNA methyltransferase 2 (DNMT2) upregulation was also shown. DNMT2-mediated RNA methylation could promote RNA stabilization upon curcumin treatment. In conclusion, a nucleolus-focused cytostatic action of curcumin at a low micromolar concentration range, which could be feasibly achieved through dietary means, was established in VSMCs and we propose a novel mechanism underlying this action. We believe that our results may contribute to better understanding of the biological and pharmacological effects of curcumin on the human cardiovascular system.


Asunto(s)
Puntos de Control del Ciclo Celular/efectos de los fármacos , Curcumina/farmacología , ADN Ribosómico/genética , Músculo Liso Vascular/efectos de los fármacos , Miocitos del Músculo Liso/efectos de los fármacos , Sirtuinas/fisiología , Aorta/efectos de los fármacos , Nucléolo Celular/efectos de los fármacos , Células Cultivadas , ADN (Citosina-5-)-Metiltransferasas/análisis , Metilación de ADN , Humanos , Masculino , Músculo Liso Vascular/citología , Miocitos del Músculo Liso/metabolismo , Oxidación-Reducción , Regiones Promotoras Genéticas , Proteínas/metabolismo , Transcripción Genética/efectos de los fármacos
11.
Postepy Biochem ; 60(2): 147-60, 2014.
Artículo en Polaco | MEDLINE | ID: mdl-25134351

RESUMEN

Development of the civilization and medicine enables an even longer lifespan of people. To modulate the aging process it is necessary to discover its molecular mechanism and its causes. It has been known for almost 60 years that cells undergo senescence. A lot of markers of senescence have been described to distinguish senescent cells. Every year we can observe an increase in the number of data, supporting the thesis that the reason for aging of the whole organism is cellular senescence. We age because cells building tissues and organs undergo senescence. It is also believed that cellular senescence can increase the frequency of age-related diseases. The role of cellular senescence strictly depends on the age of the individual. In young ones it is essential for: protection against cancer and tissue regeneration. In old ones it causes tissues and organs dysfunctions and leads to age-related diseases. Slowing down aging could prevent age-related diseases and this seems to be more promising than curing them. To enrich our knowledge concerning aging it is important to understand signaling pathways leading to senescence. Recently a new role of cellular senescence has been discovered, namely during embryogenesis. This observation is very surprising and shows a new face of cellular senescence. It is possible that, similarly to the previously described role of apoptosis in embryogenesis, senescence is indispensable for proper organogenesis. Cellular senescence seems to be the universal and fundamental process, the role of which changes during the lifespan.


Asunto(s)
Envejecimiento/fisiología , Senescencia Celular/fisiología , Enfermedad Crónica , Envejecimiento/patología , Animales , Apoptosis , Desarrollo Embrionario/fisiología , Humanos , Neoplasias/metabolismo , Neoplasias/patología , Organogénesis/fisiología , Estrés Oxidativo , Transducción de Señal
12.
Chem Biol Interact ; 220: 51-63, 2014 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-24928743

RESUMEN

Because applications of nanomaterials in nanomedicine and nanotechnology are rapidly increasing, nanodiamond (ND) health risk assessment is urgently needed. In the present study, we used HeLa cell model to evaluate nanodiamond biocompatibility. We found ND-mediated cytotoxicity, proliferation inhibition and oxidative stress. Conversely, ND-associated genotoxicity was limited to higher concentrations used. Nanodiamond was also recognized as a hypermethylating agent. ND-associated redox imbalance contributed to nucleolar stress: size and number of nucleoli were affected, and release of nucleolar protein RRN3 occurred. Surprisingly, we did not observe stress-induced RNA depletion. In contrast, RNA was stabilized: total RNA level and integrity (28S/18S rRNA ratio) were unaffected. After nanodiamond treatment, upregulation of DNA methyltransferase 2 (DNMT2) was shown. Perhaps, DNMT2, as a part of the regulatory loop of metabolic pathways through RNA methylation, may contribute to RNA stabilization and confer stress resistance after nanodiamond treatment. In conclusion, using HeLa cell model, we showed that ND biocompatibility is limited and special care should be taken when introducing ND-based biomaterials to biological systems.


Asunto(s)
Nucléolo Celular/efectos de los fármacos , ADN (Citosina-5-)-Metiltransferasas/genética , Nanodiamantes/toxicidad , Estrés Oxidativo/efectos de los fármacos , Regulación hacia Arriba/efectos de los fármacos , Adenosina Trifosfato/metabolismo , Proliferación Celular/efectos de los fármacos , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Femenino , Citometría de Flujo , Células HeLa , Humanos
13.
Biogerontology ; 15(1): 47-64, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24243065

RESUMEN

Senescence of vascular smooth muscle cells (VSMCs) contributes to aging as well as age-related diseases of the cardiovascular system. Senescent VSMCs have been shown to be present in atherosclerotic plaques. Both replicative (RS) and stress-induced premature senescence (SIPS) accompany cardiovascular diseases. We aimed to establish the signature of RS and SIPS of VSMCs, induced by a common anticancer drug, doxorubicin, and to discover the so far undisclosed features of senescent cells that are potentially harmful to the organism. Most of the senescence hallmarks were common for both RS and SIPS; however, some differences were observed. 32 % of doxorubicin-treated cells were arrested in the G2/M phase of the cell cycle, while 73 % of replicatively senescing cells were arrested in the G1 phase. Moreover, on the basis of alkaline phosphatase activity measurements, we show that a 7-day treatment with doxorubicin (dox), does not cause precocious cell calcification, which is a characteristic feature of RS. We did not observe calcification even though after 7 days of dox-treatment many other markers characteristic for senescent cells were present. It can suggest that dox-induced SIPS does not accelerate the mineralization of vessels. We consider that detailed characterization of the two types of cellular senescence can be useful in in vitro studies of potential anti-aging factors.


Asunto(s)
Envejecimiento Prematuro/inducido químicamente , Envejecimiento Prematuro/patología , Aorta/citología , Proliferación Celular , Senescencia Celular/fisiología , Doxorrubicina/efectos adversos , Músculo Liso Vascular/citología , Envejecimiento Prematuro/fisiopatología , Fosfatasa Alcalina/metabolismo , Ciclo Celular/efectos de los fármacos , Ciclo Celular/fisiología , Línea Celular , Células Cultivadas , ADN (Citosina-5-)-Metiltransferasa 1 , ADN (Citosina-5-)-Metiltransferasas/metabolismo , Relación Dosis-Respuesta a Droga , Doxorrubicina/farmacología , Humanos , Técnicas In Vitro , Masculino , Músculo Liso Vascular/fisiología , Superóxidos/metabolismo , Homeostasis del Telómero/fisiología , Adulto Joven , beta-Galactosidasa/metabolismo
14.
Biochimie ; 97: 163-72, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24148276

RESUMEN

Bovine papillomavirus 1 (BPV-1) is a well recognized etiopathogenetic factor in a cancer-like state in horses, namely equine sarcoid disease. Nevertheless, little is known about BPV-1-mediated cell transforming effects. It was shown that BPV-1 triggers genomic instability through DNA hypomethylation and oxidative stress. In the present study, we further characterized BPV-1-positive fibroblasts derived from sarcoid tumors. The focus was on cancer-like features of sarcoid-derived fibroblasts, including cell cycle perturbation, comprehensive DNA damage analysis, end-replication problem, energy metabolism and oncogene-induced premature senescence. The S phase of the cell cycle, polyploidy events, DNA double strand breaks (DSBs) and DNA single strand breaks (SSBs) were increased in BPV-1-positive cells compared to control fibroblasts. BPV-1-mediated oxidative stress may contribute to telomere dysfunction in sarcoid-derived fibroblasts. Loss of mitochondrial membrane potential and concurrent elevation in intracellular ATP production may be a consequence of changes in energy-supplying pathways in BPV-1-positive cells which is also typical for cancer cells. Shifts in energy metabolism may support rapid proliferation in cells infected by BPV-1. Nevertheless, sarcoid-derived fibroblasts representing a heterogeneous cell fraction vary in some aspects of metabolic phenotype due to a dual role of BPV-1 in cell transformation and oncogene-induced premature senescence. This was shown with increased senescence-associated ß-galactosidase (SA-ß-gal) activity. Taken together, metabolic phenotypes in sarcoid-derived fibroblasts are plastic, which are similar to greater plasticity of cancer tissues than normal tissues.


Asunto(s)
Metabolismo Energético , Fibroblastos/metabolismo , Inestabilidad Genómica , Enfermedades de los Caballos/patología , Infecciones por Papillomavirus/veterinaria , Neoplasias Cutáneas/veterinaria , Animales , Papillomavirus Bovino 1 , Ciclo Celular , Transformación Celular Neoplásica/genética , Transformación Celular Neoplásica/metabolismo , Transformación Celular Neoplásica/patología , Senescencia Celular , Roturas del ADN de Doble Cadena , Roturas del ADN de Cadena Simple , ADN Viral/genética , Fibroblastos/patología , Fibroblastos/virología , Expresión Génica , Enfermedades de los Caballos/metabolismo , Enfermedades de los Caballos/virología , Caballos , Estrés Oxidativo , Infecciones por Papillomavirus/metabolismo , Infecciones por Papillomavirus/patología , Infecciones por Papillomavirus/virología , Ploidias , Neoplasias Cutáneas/metabolismo , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/virología , beta-Galactosidasa/genética , beta-Galactosidasa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...